What Is Neural Networks and Machine Learning in Biology — And Why Does It Matter?

Image generated by AI

Your brain contains roughly 86 billion neurons, each connected to thousands of others through synapses that strengthen or weaken based on experience. But here’s the surprise: artificial neural networks—mathematical systems inspired by this biological architecture—are now being used to decode the very brain that inspired them. Machine learning algorithms are peering into biological systems with unprecedented clarity, predicting how proteins fold, how cancer cells evolve, and even how neural circuits process the world around us. The boundary between how biology works and how we model biology is blurring in ways that could reshape medicine and our understanding of life itself.

We stand at a peculiar moment in science where artificial intelligence, originally conceived as a mirror of biological intelligence, has become essential for understanding biology at scales and speeds human researchers never could. From AlphaFold’s revolutionary prediction of protein structures to machine learning models that diagnose diseases from medical images faster and more accurately than radiologists, these computational approaches are no longer supplementary tools—they are central to modern biological discovery. As biological data accumulates faster than humans can analyze it, neural networks have become indispensable, yet many people remain unclear about what they are, how they mimic biological processes, or why they matter for medicine, biotechnology, and our future.

What Is Neural Networks and Machine Learning in Biology?

Neural networks are computational systems loosely inspired by how neurons and synapses work in biological brains. They consist of interconnected layers of artificial “neurons”—mathematical units that receive inputs, process them through weighted connections, and produce outputs that feed into the next layer. Machine learning, more broadly, refers to algorithms that improve their performance on a task through experience and data rather than following explicit step-by-step instructions. When applied to biology, these techniques allow computers to find hidden patterns in vast datasets—from genetic sequences to cell images to protein structures—without being programmed with explicit rules about what to look for. Think of it as teaching a computer system to see like a biologist: show it thousands of examples, let it find patterns, and soon it can make predictions about things it has never explicitly seen before.

The conceptual foundations of neural networks trace back to the 1940s, when Warren McCulloch and Walter Pitts published a groundbreaking paper describing how biological neurons could be modeled mathematically. However, practical neural networks didn’t emerge until the 1950s and 1960s, when researchers like Frank Rosenblatt developed the “perceptron,” a simple machine learning algorithm that could learn to classify patterns. The field experienced multiple “winters” when enthusiasm waned due to computational limitations, but it experienced a renaissance in the 2010s with the rise of “deep learning”—neural networks with many layers—powered by GPUs and massive datasets. In biology specifically, the application of machine learning accelerated dramatically after 2016, when Google’s DeepMind began applying deep learning to fundamental biological problems, most famously with AlphaFold’s solution to protein folding in 2020. This moment marked a shift: machine learning went from a promising tool to a cornerstone technology in computational biology.

How It Works in Nature

To understand how neural networks help us understand biology, we must first grasp how biological neural networks learn. In your brain, when you learn something new—like recognizing a friend’s face—connections between neurons are strengthened through a process called synaptic plasticity. Specifically, when neurons fire together repeatedly, the synapse between them becomes stronger, a principle captured in the famous neuroscientific saying “neurons that fire together wire together.” This simple learning rule, repeated across billions of synapses, allows your brain to extract meaningful patterns from experience. The strength of each connection is, in essence, a “weight” that determines how strongly one neuron influences the next. Machine learning systems operate on remarkably similar principles: artificial neurons have weighted connections, information flows through layers, and during training, these weights are adjusted based on errors until the system can accurately recognize or predict patterns.

Consider how a neural network might learn to identify cancer cells in a microscopy image. You show it thousands of labeled examples—images marked as “cancer” or “healthy”—and the network adjusts its weights layer by layer, essentially learning to recognize subtle visual features that distinguish healthy cells from cancerous ones. The first layers might learn to detect simple features like edges and colors, middle layers combine these into more complex patterns like cell shapes, and deeper layers learn abstract features that correspond to actual biological hallmarks of cancer. This mirrors how your own visual cortex processes images, with early stages handling simple features and later stages building toward meaningful interpretation. The crucial difference is speed and scale: a trained neural network can analyze thousands of images in seconds, a feat that would take human pathologists months.

Medical and Scientific Relevance

The implications for medicine are staggering. Machine learning systems are now being deployed to diagnose diseases from medical imaging with accuracy matching or exceeding that of experienced specialists. In oncology, neural networks analyze pathology slides to detect cancer subtypes, grade tumors, and even predict treatment response. In cardiology, machine learning models identify patients at risk of heart disease from ECG patterns invisible to human analysis. In genomics, these algorithms parse billions of DNA sequences to identify disease-causing mutations, predict how genetic variants affect protein function, and accelerate drug discovery by predicting which compounds will bind to disease-related targets. Beyond diagnosis and drug discovery, machine learning is transforming how we understand disease mechanisms—neural networks trained on gene expression data can predict how cells will respond to perturbations, essentially giving us a computational model of cellular biology that we can interrogate faster than bench experiments.

Real-world applications are multiplying rapidly. Google’s DeepMind developed AlphaFold, which solved the 50-year-old protein folding problem by predicting 3D protein structures from amino acid sequences—a breakthrough that has already accelerated structural biology research across academia and industry. In diagnostic imaging, companies like Zebra Medical Vision and Tempus use neural networks to detect diseases in mammograms, CT scans, and other medical images, often identifying subtle abnormalities that might escape human notice. In drug development, machine learning systems like those developed by companies such as DeepMind, Recursion Pharmaceuticals, and Atomwise are screening millions of compounds computationally before expensive lab tests, dramatically reducing time and cost. Hospitals are deploying machine learning for sepsis prediction, patient triage, and personalized treatment planning. These are not speculative future applications—they are operational systems affecting clinical care today.

Recent Breakthroughs in Neural Networks and Machine Learning in Biology

The past two to three years have witnessed extraordinary advances that suggest we are entering a new era of machine learning in biology. In 2022, DeepMind released AlphaFold2’s structure predictions for virtually every known protein in major organisms—over 200 million structures—making structural data freely available to the global research community. This represented a shift from solving isolated problems to providing fundamental biological infrastructure. Simultaneously, transformer-based neural networks—a specific architecture that excels at processing sequential data—began dominating bioinformatics, with models like ESM (Evolutionary Scale Modeling) learning representations of protein sequences that capture evolutionary and functional information in ways that enable new discoveries. In 2023 and 2024, researchers demonstrated that these protein language models could predict the effects of genetic mutations, identify promising antibodies, and even design novel proteins with desired functions that don’t exist in nature. Foundation models—large neural networks trained on vast biological datasets and then fine-tuned for specific tasks—emerged as a paradigm shift, similar to how GPT models transformed natural language processing.

Current research frontiers include designing entirely new proteins using neural networks, predicting how single genetic mutations contribute to disease across millions of variants, and building comprehensive models of cellular decision-making and cell-to-cell communication. Researchers are investigating how neural networks might predict drug toxicity and side effects earlier in development, potentially preventing harmful drugs from reaching clinical trials. Another frontier involves interpretability—understanding what neural networks actually learn about biology, moving beyond “black box” predictions toward systems that can explain their reasoning in ways that advance biological understanding. Open questions persist: Can machine learning help us understand emergence and complex systems in biology, like how individual cell behaviors give rise to organ function? How do we ensure these powerful systems work equitably across diverse genetic backgrounds and populations? And can we integrate machine learning with mechanistic biological understanding rather than treating them as separate approaches?

Why Neural Networks and Machine Learning in Biology Matters for the Future

The convergence of machine learning and biology will likely reshape medicine, agriculture, and biotechnology in the coming decades. As we face global challenges like pandemic preparedness, antibiotic resistance, and food security, machine learning offers tools to accelerate solutions that might otherwise take years to discover. Imagine neural networks trained to identify which naturally occurring compounds can kill drug-resistant bacteria, or which genetic modifications might make crops resilient to changing climates—these are not distant possibilities but active research areas. More profoundly, machine learning may help us achieve one of biology’s ultimate goals: a truly predictive, mechanistic understanding of life at all scales, from molecules to ecosystems. By finding patterns humans miss in vast biological datasets, these systems reveal how biology actually works, potentially leading to entirely new therapeutic approaches or biological engineering capabilities we cannot yet envision.

However, significant challenges remain. Neural networks require enormous amounts of high-quality data, which remains scarce for rare diseases and underrepresented populations, risking that machine learning advances primarily benefit those in wealthy, data-rich regions. There are concerns about bias in training data leading to disparate performance across patient populations. The computational resources required to train large models are substantial, raising questions about accessibility and environmental impact. Many neural networks remain poorly interpretable—we can use them to make predictions but struggle to understand why they make those predictions, which limits their utility for fundamental discovery and raises safety concerns in clinical applications. Additionally, much biological knowledge is still encoded in scientific literature rather than structured databases that machine learning systems can easily learn from, representing an untapped resource but also a practical challenge.

Key Takeaways

• Neural networks and machine learning are computational systems inspired by biological brains that excel at finding patterns in biological data, from protein sequences to medical images, at scales and speeds far exceeding human capability.
• These systems learn through repeated exposure to examples, adjusting weighted connections between artificial neurons until they can accurately recognize or predict biological phenomena—a process fundamentally similar to how biological brains learn.
• Machine learning applications in biology already include disease diagnosis, drug discovery, protein structure prediction, and personalized medicine, with systems like AlphaFold and diagnostic AI already operational in research and clinical settings.
• Recent breakthroughs in transformer-based models and foundation models represent a shift toward general-purpose biological AI systems, though challenges around interpretability, bias, and data access remain significant barriers.
• As biological data continues to accumulate exponentially, machine learning will become increasingly central to biological discovery, potentially accelerating solutions to major challenges in medicine, agriculture, and environmental biology.